Hematoloji

Bayındır Söğütözü Hastanesi

Bayındır Söğütözü Hastanesi

Eğitim

Kariyer

Üyelikler

Yayınlar

Uluslararası Yayınlar

1) Plasma Endothelin-1 Concentrations in Patients with Behçet’s Disease. A. Uğur Ural, Atilla Yalçın, Cengiz Beyan, Aşkın Işımer, Hikmet Bayhan. Scandinavian Journal of Rheumatology. 23: 322-325, 1994

2) A Case of Hb J- Meerut (or Hb J-Birmingham) [a 120 (H3) ALA®GLU]. Atilla Yalçın, Ferit Avcu, Cengiz Beyan, Aytemiz Gürgey, A. Uğur Ural. Hemoglobin. 18(6): 433-435, 1994

3) Acute Promyelocytic Leukemia In The Course Of Acromegaly: A Case Report. Cengiz Beyan, A. Uğur Ural, Türker Çetin, Metin Özata, Atilla Yalçın. Endocrine Journal. 43(5): 565-568, 1996

4) Scurvy Presenting with Cutaneous and Articular Signs and Bicytopenia. Atilla Yalçın, A. Uğur Ural, Cengiz Beyan, Bülent Taştan, Murat Demiriz, Türker Çetin. International Journal of Dermatology. 35(12): 879-881, 1996

5) Uncommon Cause Of Severe Pancytopenia: Toxoplasmosis. Cengiz Beyan, A. Uğur Ural, Türker Çetin, Serdar B. Omay, Levent Doğancı, Atilla Yalçın. American Journal of Hematology. 55: 164, 1997

6) Anemia Related to Ascorbic Acid Deficiency. A. Uğur Ural. American Journal of Hematology. 56: 69, 1997

7) Increased Plasma Endothelin-1 Levels in Active Behçet’s Disease. A. Uğur Ural. Clinical Rheumatology. 16(6): 640, 1997

8) Thrombocytopenia Following Intravenous Iopamidol. A. Uğur Ural, Cengiz Beyan, Atilla Yalçın. European Journal of Clinical Pharmacology. 54(7):575, 1998

9) Effects of Hydroxyethl Starch on Blood Coagulation Profile. Hülya Türkan, A. Uğur Ural, Cengiz Beyan, Atilla Yalçın. European Journal of Anaesthesiology. 16(3): 156-9, 1999

10) Comment: Spironolactone Prevents Amphotericin B-Induced Hypokalemia in Neutropenic Patients. A. Uğur Ural. Annals of Pharmacotherapy. 34(12); 1488, 2000

11) Chronic Myelomonocytic Leukemia Developed 2 Years After the Onset of Immune Thrombocytopenic Purpura Like Syndrome. A. Uğur Ural, Kürşad Kaptan, Ferit Avcu, Şefik Güran, Cengiz Beyan, Özlem Durmuş, Atilla Yalçın. Haematologia. 30(3):221-224, 2000

12) Gene Therapy for Endometrial Carcinoma with the Herpes Simplex Thymidine Kinase Gene. A. Uğur Ural, Naoko Takebe, Debasis Adhikari, Emine Erçıkan-Abalı, Debabrata Banerjee, Richard Barakat, Joseph R. Bertino. Gynecologic Oncology. 76: 305-310, 2000

13) Helicobacter Pylori: Is a Novel Causative Agent in Vitamin B12 Deficiency? Kürşad Kaptan, Cengiz Beyan, A. Uğur Ural, Türker Çetin, Ferit Avcu, Mustafa Gülşen, Rıfkı Finci, Atilla Yalçın. Archives of Internal Medicine. 160: 1349-53, 2000

14) Comparison of Methotrexate Resistance Conferred Mutated Dihydrofolate Reductase (DHFR) cDNA in Two Different Retroviral Vectors. Naoko Takebe, Saori Nakahara, Shi-Cheng Zhao, Debasis Adhikari, A. Uğur Ural, Iwamoto M, Debabrata Banerjee, Joseph R. Bertino. Cancer Gene Therapy. 7(6): 910-9, 2000

15) Erythema Annulare Centrifugum as the Presenting Sign of non-Hodgkin Lymphoma-Association with Disease Activity. A. Uğur Ural, Ayhan Özcan, Ferit Avcu, Kürşad Kaptan, Bülent Taştan, Cengiz Beyan, Atilla Yalçın. Haematologia. 31(1): 81-84, 2001

16) Combination Chemotherapy with Theophylline in Chronic Lymphocytic Leukemia. A. Uğur Ural. Haematologia. 31(1): 85-86, 2001

17) Successful treatment of severe aplastic anemia associated with human parvovirus B19 and Epstein-Barr virus in a healthy subject with allo-BMT. Kürşad Kaptan, Cengiz Beyan, A. Uğur Ural, Celalettin Üstün, Türker Çetin, Ferit Avcu, Ayhan Kubar, Metin Alış, Atila Yalçın. American Journal of Hematology. 67(4):252-5, 2001

18)Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+- enriched peripheral blood progenitor cells. Naoko Takebe, Shi-Cheng Zhao, A. Uğur Ural, Martin R. Johnson, Debabrata Banerjee, Robert B. Diaso, Joseph R. Bertino. Cancer Gene Therapy. 8: 966-973, 2001

20 The Relationship Between Gastric-Oral Helicobacter pylori and Oral Hygiene in Patients with Vitamin B12 Deficiency Anemia. Nihal Avcu, Ferit Avcu, Cengiz Beyan, A. Uğur Ural, Kürşad Kaptan, Mustafa Özyurt, Oral Nevruz, Atilla Yalçın. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 92(2):166-9, 2001

21 Does amphotericin B lipid complex (Abelcet) affect haematological parameters erroneously? Cengiz Beyan, Türker Çetin, Kürşad Kaptan, A. Uğur Ural, Atilla Yalçın. Haematologia (Budap). 31(3):245-9, 2001

22 Spironolactone: Is it a novel drug for the prevention of Amphotericin-B related hypokalemia in cancer patients. A. Uğur Ural, Ferit Avcu, Türker Çetin, Cengiz Beyan, Kürşad Kaptan, N. Kemal Nazaroğlu, Atilla Yalçın. European Journal of Clinical Pharmacology. 57: 771-773, 2002

23 Lack of platelet aggregation abnormality in Hodgkin's disease. Kürşad Kaptan, Cengiz Beyan, Bekir Öztürk, Türker Çetin, A. Uğur Ural, Ferit Avcu, Celalettin Üstün, Atila Yalçın. Haematologia (Budap). 31(4):357-63, 2002

24 Anemia following human parvovirus B19 infection in a patient with polycythemia vera. Kürşad Kaptan, Cengiz Beyan, Türker Çetin, A. Uğur Ural, Celalettin Üstün, Ferit Avcu, Oral Nevruz, Çakır Güney, Ayhan Kubar. American Journal of Hematology. 69(4):296-7, 2002

25 Severe thrombocytopenia as a presenting symptom of hepatitis C virus infection. Cengiz Beyan, Türker Çetin, Kürşad Kaptan, Oral Nevruz, A. Uğur Ural, Ferit Avcu, Ayhan Kubar, Atilla Yalçın. Haematologia. 32(3):277-80, 2002

26 Treatment with Cerivastatin in primary mixed hyperlipidemia induces changes in the platelet aggregation and coagulation system components. A. Uğur Ural, M.İlker Yılmaz, Ferit Avcu, Atilla Yalçın. International Journal of Hematology. 76(3):279-283, 2002

27 Increasing the target number of nucleated cells and administration of r-metHuG-CSF expedite neutrophil engraftment in allogeneic bone marrow transplantation. Kürşad Kaptan, Celalettin Üstün, Cengiz Beyan, A. Uğur Ural, Ferit Avcu, Türker Çetin, Bekir Öztürk, Ali Şengül, Aysel Pekel, D.Sertkaya, Yücel Pak, RE Burgess, Atilla Yalçın. Transplant Proceedings. 34(4):1310-4, 2003

28 Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia. Kürşad Kaptan, A. Ugur Ural, Türker Çetin, Ferit Avcu, Cengiz Beyan, Atilla Yalçın. J Infect Chemother.9(1):40-5, 2003

29 The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide. A. Ugur Ural, M. Ilker Yılmaz, Ferit Avcu, Aysel Pekel, Murat Zerman, Oral Nevruz, Ali Şengül, Atilla Yalçın. International Journal of Hematology. 78(5):443-449, 2003

30 The Bisphosphonate Zoledronic Acid Inhibits the Development of Plasmacytoma Induced in BALB/c Mice by Intraperitoneal Injection of Pristane. Ferit Avcu, A. Ugur Ural, M. Ilker Yılmaz, Ayhan Ozcan, Tayfun Ide, Bulent Kurt, Atilla Yalçın. European Journal of Hematology. 74:1-5, 2005

31 Identification of Polymorphisms on MDR1 Gene Among Turkish Population and Their Effects on Multidrug Resistance in Acute Luekemia Patients. Pelin Kaya, Ufuk Gündüz, Fikret Arpacı, A. Ugur Ural, Şefik Güran. American Journal of Hematology. 80;26-34, 2005

32 In vitro IL-1ß Release from Gingival Fibroblasts in Response to Pure Metals, Dental Alloys and Ceramic. Julide Özen, Arzu Atay, Bedri Beydemir, Muhittin Serdar, A. Ugur Ural, Mehmet Dalkız, Yasemin Soysal. Journal of Oral Rehabilitation. 32;511-517, 2005

Serum and Follicular Fluid Levels of Soluble Fas, Soluble Fas Ligand and Apoptosis of Luteinized Granulosa Cells in PCOS patients Undergoing IVF Cycles. Göğsen Önalan, Belgin Selam, Yusuf Baran, Reside Önalan, Ufuk Gündüz, A. Ugur Ural, Recai Pabucçu. Human

33 Leukopenia and thrombocytopenia possibly associated with lamotrigine use in a patient. A. Uğur Ural, Ferit Avcu, Zeki Gökçil, Oral Nevruz, Türker Çetin. Epileptic Disorders. 7(1):1-3, 2005

34 Development of squamous cell carcinoma of the tongue during induction chemotherapy for acute myeloid leukemia. A. Uğur Ural, Ferit Avcu, M. İlker Yılmaz, Metin Güden, Bekir Öztürk, Ayhan Özcan, Şefik Güran, Muhterem Bahçe, Atilla Yalçın. Tumori. 91:81-83,2005

35 Evolving therapeutic role of bisphosphonates in multiple myeloma. A. Uğur Ural, Ferit Avcu. British Journal of Cancer. 93:267-268, 2005

36 Radiosensitizing effect of zoledronic acid in small cell lung cancer. A. Uğur Ural, Ferit Avcu. Lung Cancer. 50:271-272, 2005

37 Bisphosphonates may potentiate radiation effects: A new approach in cancer treatment. A. Uğur Ural, Ferit Avcu. Biochemical and Biophysical Research Communications. 336:373-374, 2005

38 Zoledronic Acid Sensitizes Tumor Cells to Radiation. A. Uğur Ural, Ferit Avcu. International Journal of Radiation Oncology, Biology, Physics. 63(3):970, 2005

39 HMG-CoA reductase inhibitors may effect thrombin generation by reducing Factor VII activity in hyperlipidemic patients. A. Uğur Ural, Ferit Avcu. Thrombosis Research, 118:665-666, 2006

40 Additive/synergistic anti-tumoral effects of the combination of docetaxel and zoledronic acid on prostate cancer cells: Possible mechanisms? A. Uğur Ural, Ferit Avcu. Acta Oncologica. 45(4):491-2, 2006

41 Bisphosphonates may Potentiate Effects of Thalidomide-Dexamethasone Combination in Advanced Multiple Myeloma. A. Uğur Ural, Ferit Avcu. American Journal of Hematology. 81(5):385-86, 2006

41 Allogeneic Stem Cell Transplantation for Hematological Malignancies and Severe Aplastic Anemia: A Single Center Experience from Turkey. Ahmet Ifran, Cengiz Beyan, A. Ugur Ural, Türker Çetin, Kürşat Kaptan, Ferit Avcu, Oral Nevruz. World Journal of Medical Sciences. 1(11):35-38, 2006

43 Development of secondary myelodysplastic syndrome in a patient with previous bladder carcinoma. Ahmet Ifran, Oral Nevruz, Ferit Avcu, Şefik Güran, A. Uğur Ural. American Journal of Hematology. 81(7):560, 2006

44 Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases. Ferit Avcu, A. Ugur Ural, İlker Yilmaz, Necati Bingol, Oral Nevruz, Kayser Caglar. International Journal of Hematology. 83(3):254-8, 2006

45 Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine. Yusuf Baran, Ufuk Gündüz, A. Ugur Ural. Experimental Oncolology. 28:163-5, 2006

46 In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells. A.Ugur Ural, Ferit Avcu, Muhammed Candir, Metin Guden, M.Ali Ozcan. Breast Cancer Research. 22;8(4), 2006

47 The effect of two fiber impregnation methods on the cytotoxicity of a glass and carbon fiber-reinforced acrylic resin denture base material on oral epithelial cells and fibroblasts. Cumhur Sipahi, Julide Ozen, A.Ugur Ural, Mehmet Dalkiz, Bedri Beydemir. Journal of Oral Rehabilitation, 33(9):666-73, 2006

48 The plasma levels of soluble P-selectin in subjects with prediabetes. Teoman Dogru, İlker Taşci, Alper Sonmez, Halil Genc, Gok M, İlker Yilmaz, A.Ugur Ural, Abdullah Olgun, Kilic S, Ergun Bozoglu, Gökhan Erdem, Kemal Erbil. Internatıonal Journal of Clinical Practice. 60(9):1048-52, 2006

49)Differentiation effect of thalidomide and GM-CSF combination on HL-60 acute promyelocytic leukemia cells. A.Ugur Ural, Ferit Avcu, Murat Zerman, M.İlker Yılmaz, Aysel Pekel, Murat

50 Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds. Kars MD, Iseri OD, Gunduz U, Ural AU, Arpaci F, Molnar J. Anticancer Research, 26(6B):4559-68, 2006

51 Oral Fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukemia. A. Ugur Ural, Ayhan Kubar, Ferit Avcu, H. Bulent Taştan, Mukerrem Safalı, Oral Nevruz, Turker Çetin. Clinical and Experimental Dermatology, 32:151-154; 2006

52 Cardiac Autonomic Functions are Altered in Patients with Acute Leukemia, Assessed by Heart Rate Variability.Oral Nevruz, Mehmet Yokusoglu, Mehmet Uzun, Sait Demirkol, Ferit Avcu, Oben Baysan, Cem Koz, Turker Cetin, Cemal Sag, A.Ugur Ural, Ersoy Isik. Tohoku J Exp Med. 2007;211(2):121-6, 2007

53 Effect of Mineral Trioxide Aggregate Cements on Transforming Growth Factor beta1 and Bone Morphogenetic Protein Production by Human Fibroblasts In Vitro. Günseli Guven, Cehreli ZC, A. Ugur Ural, Muhittin Serdar, Feridun Basak. J Endod. 33(4):447-50, 2007

54 The altered autonomic nervous system activity in iron deficiency anemia. Mehmet Yokusoglu, Oral Nevruz, Oben Baysan, Mehmet Uzun, Demirkol S, Avcu F, Cem Koz, Türker Cetin, Adnan Hasimi, A. Ugur Ural, Ersoy Isik. Tohoku J Exp Med. 212(4):397-402, 2007

55 Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells. Yusuf Baran, A. Ugur Ural, Ufuk Gunduz. Hematology. 12(6):497-503, 2007

56 Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance. Yusuf Baran, Bala Gur, Pelin Kaya, A. Ugur Ural, Ferit Avcu, Ufuk Gunduz. Hematology. 12(6):511-7, 2007

57 Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro. Ferit Avcu, A. Ugur Ural, Türker Cetin, Oral Nevruz. Thromb Res. 121(4):567-71, 2007

58 Synthesis of 3-substituted-5-(4-carb oxycyclohexylmethyl) - tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives as antifibrinolytic and antimicrobial agents. Ozcelik AB, Seyhan Ersan, A. Ugur Ural, Ozkan S, Ertan M. Arzneimittelforschung. 2007;57(8):554-9, 2007

59) Platelet aggregation is not enhanced in patients with prediabetes. Teoman Dogru, Halil Genç, İlker Taşçı, Alper Sönmez, Gökhan Erdem, A. Ugur Ural, Ferit Avcu, Serap Savaşçı, Selim Kılıç, Selahattin Erikçi. Upsala J Med Sci. 112(3): 338-346, 2007.

60) Cytotoxic effects of four different endodontic materials in human periodontal ligament fibroblasts. Melahat Görduysus, Nihal Avcu, Ömer Görduysus, Aysel Pekel, Yusuf Baran, Ferit Avcu, A. Ugur Ural. J Endod. 33(12):1450-4, 2007

61) In Vitro Evaluation of Zoledronic Acid Resistance Developed in MCF-7 Cells. Meltem Demirel Kars, Özlem Darcansoy İşeri, A. Ugur Ural, Ufuk Gündüz. Anticancer Res. 27: 4031-4038, 2007

62 Chronic myeloid leukemia following radiotherapy for carcinoma of the cervix: Report of a case and brief review of the literature. A. Ugur Ural, Murat Beyzadeoğlu, Ferit Avcu, Oral Nevruz. American Journal of Hematology, 82(5):415-6, 2007

63) Radiological evidence of double inferior vena cava in a young adult male. Oral Nevruz, Yalcin Kirici, Cenk Kilic, Ugur Bozlar, A. Uğur Ural, Saudia Medical Journal, 28(3):454-6, 2007

64) Glanzmann's thrombasthenia in two pregnant females. Murat Dede, A. Ugur Ural, Mufit Yenen, Zeki Mesten, Iskender Başer. American Journal of Hematology, 82(4):330-1, 2007

65) Bisphosphonates may decrease radiation-related cardiac side effects with their radiosensitizing effects. A. Uğur Ural, Ferit Avcu, Yusuf Baran, Cancer, 110(2):469-70, 2007

66) Therapeutic Role of Bisphosphonate and Radiation Combination in the Management of Myeloma Bone Disease, A. Uğur Ural, Ferit Avcu, Clin Cancer Res;13(11):3432, 2007

67) Multiple gestation in an essential thrombocythemia patient treated with interferon-alpha. Oral Nevruz, Ümit Goktolga, Ferit Avcu, Levent Ozsari, A. Ugur Ural. Acta Obstet Gynecol Scand. 86(7):893-5, 2007

68) Bisphosphonates May Increase Peritoneal Fibrinolytic Activity by Inhibiting the Mevalonate Pathway. A. Ugur Ural, Ferit Avcu, Suzi Demirbag. Ann Surg. 247(1):203-204, 2008

69) Bisphosphonate treatment and radiotherapy in metastatic breast cancer. A. Ugur Ural, Ferit Avcu, Yusuf Baran. Med Oncol. 25(3):350-5, 2008

70 Bisphosphonates may retrieve endothelial function in vascular diseases similar to statins' effects. A. Ugur Ural, Ferit Avcu, Kamile Ozturk. Eur J Haematol. 81(1):77-8, 2008

71 Antithrombotic challenges after coronary artery surgery in patients with polycytemia vera. A.Ugur Ural, Türker Cetin, Ferit Avcu. J Card Surg. 23(4):410, 2008

72 Progress in the molecular biology of inherited bleeding disorders. Steven Pipe, Kathy High, Kazuo Ohashi, A. Ugur Ural, David Lillicrap. Haemophilia. 14(Suppl.3)130-137, 2008.

73 Adipose tissue 11-beta-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-Phosphate Dehydrogenase gene expressions are increased in patients type 2 diabetes mellitus. Gökhan Üçkaya, Nuri Karadurmuş, Onur Kutlu, Ahmet Çorakçı, Sefa Kızıldağ, A. Ugur Ural, Davut Gül, Mustafa Kutlu. Diabetes Research and Clinical Practice, 82 Suppl 2:S135-40, 2008

74 Effects of laser irradiation on the release of basic fibroblast growth factor (bFGF), insulin like growth factor-1 (IGF-1), and receptor of IGF-1 (IGFBP3) from gingival fibroblasts. Işıl Saygun, Şeniz Karacay, Muhittin Serdar, A. Ugur Ural, Sencimen M, Kurtis B. Lasers Med Sci. 23(2):211-5, 2008

75 The effects of one-step self-etch adhesives on the induction of oxidative stress and production of TGF-beta1 and BMP-2 by human gingival fibroblasts. Guven G, Cehreli SB, Altun C, Cehreli ZC, Serdar MA, A. Ugur Ural. J Biomater Sci Polym Ed. 20(11):1597-610, 2009

76 Repair of transected facial nerve with mesenchymal stromal cells: histopathologic evidence of superior outcome. Satar B, Karahatay S, Kurt B, A. Ugur Ural, Safali M, Avcu F, Oztas E, Kucuktag Z. Laryngoscope. 119(11):2221-5, 2009

77) The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high-dose chemotherapy in patients with Stage III breast cancer. Arpaci F, Safali M, Ozet A, A. Ugur Ural, Cetin T, Ozturk M, Ataergin S, Kuzhan O, Komurcu S, Ozturk B, Acikel C. J Clin Apher. 24(5):197-204, 2009

78 A rare initial manifestation of acute lymphocytic leukemia: bilaterally enlarged kidneys and liver. Basaran Y, Sayin S, Erdem G, Nevruz O, A. Ugur Ural. Intern Med. 48(17):1541-4, 2009

79) Familial Hodgkin's lymphoma from the perspective of HLA. Sonmez M, Erkut N, Ucar F, Buruk K, Cobanoglu U, Bahce M, A. Ugur Ural. Intern Med. 49(6):607-10, 2010

80 Promoted regeneration of transected facial nevre branches using mesenchymal stromal cells in relation with apoptosis: 9-month results. Bülent Satar, Emin Öztaş, Yusuf Hıdır, Esra Erdoğan, Zülküf Küçüktağ, Serpil Oğuztüzün, Serdar Karahatay, Ali Uğur Ural, Ferit Avcu, Bülent Kurt, Mükerrem Safalı. Int Adv Otol. 6(2):160-166, 2010

81 Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity in Androgen Independent Human Prostate Cancer Cells. Goktas S, Baran Y, A. Ugur Ural, Yazici S, Aydur E, Basal S, Avcu F, Pekel A, Dirican B, Beyzadeoglu M. Urology. 75(4):793-8, 2010

82 Comparison of lymphomonuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients. Levent Özsarıi Nuri Karadurmuş, M.Şahin, Gökhan Üçkaya, A. Ugur Ural, Mustafa Kutlu. Endocrine 27:135-139, 2010

83 Effect of cobalt-60 (γ radiation) on multidrug-resistant multiple myeloma cell lines. Mutlu P, Baran Y, Ural AU, Avcu F, Dirican B, Beyzadeoglu M, Gündüz U. Cell Biol Int. 35(7):721-5, 2011

84) A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes. Gencer EB, Ural AU, Avcu F, Baran Y. Ann Hematol. 90(11):1265-75, 2011

85) Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells. Camgoz A, Gencer EB, Ural AU, Avcu F, Baran Y. Leuk Lymphoma. 52(8):1574-84, 2011

86) Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: The impact of metabolic syndrome. Genc H, Dogru T, Tapan S, Tasci I, Bozoglu E, Gok M, Aslan F, Celebi G, Erdem G, Avcu F, Ural AU, Sonmez A. Clin Biochem. 45(1-2):92-5, 2012

87) Aberrant expressions of leptin and adiponectin receptor isoforms in chronic myeloid leukemia patients. Ozturk K, Avcu F, Ural AU. Cytokine. 2012 Jan;57(1):61-7, 2012

88) Low-level laser irradiation affects the release of basic fibroblast growth factor (bFGF), insulin-like growth factor-I (IGF-I), and receptor of IGF-I (IGFBP3) from osteoblasts. Saygun I, Nizam N, Ural AU, Serdar MA, Avcu F, Tözüm TF. Photomed Laser Surg. 30(3):149-54, 2012

89) Protein profiling of anastomosed facial nerve treated with mesenchymal stromal cells. Satar B, Hidir Y, Serdar MA, Kucuktag Z, Ural AU, Avcu F, Safali M, Oguztuzun S. Cytotherapy. 14(5):522-8, 2012

90) Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line. Mutlu P, Ural AU, Gündüz U. Biomed Pharmacother. 66(3):228-31, 2012

91) Differential oncogene-related gene expressions in myeloma cells resistant to prednisone and vincristine. Mutlu P, Ural AU, Gündüz U. Biomed Pharmacother. 66(7):506-11, 2012

92) The histopathologic, pharmacologic and urodynamic results of mesenchymal stem cell's injection into the decompensated rabbit's bladder. Dayanc M, Kibar Y, Ural AU, Onguru O, Yildiz O, Irkilata HC, Avcu F, Soner BC, Ulku C, Seyrek M. Stem Cell Rev. 8(4):1245-53, 2012

93) Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance. Camgoz A, Gencer EB, Ural AU, Baran Y. Leuk Lymphoma. 2012 Nov 20. [Epub ahead of print]

94) Biomechanical analysis of the effect of mesenchymal stem cells on mandibular distraction osteogenesis. Aykan A, Ozturk S, Sahin I, Gurses S, Ural AU, Oren NC, Isik S. J Craniofac Surg. 24(2):e169-75, 2013
 

Diğer Bilimsel Aktiviteler

- Yayınlara 600 üzerinde atıf
- 200 üzerinde yurtdışı veya yurtiçi kongrelerde sunulmuş tebliğ
- 30 üzerinde kitapta bölüm yazarlığı
- 60 üzerinde bilimsel sempozyum, kongre veya kurslarda yapılmış sunum veya eğitici

Uzmanlık Alanları

Otolog ve Allojeneik Kök Hücre Nakli

Akut ve Kronik Lösemiler

Multiple Myeloma

Lenfomalar (Hodgkin ve Non-Hodgkin hastalığı)

Hematopoetik ve Mezankimal Kök Hücre Farklılaştırılması, Tedavileri

Kemoterapötik İlaç Direnç Mekanizmaları

Hücre- Doku Kültürü, Sitotoksisite ve Hücre Ölümü

Ödüller

loading
x

Randevu Al

* listenenler dışındaki tarih ve saate randevu almak istiyorsanız lütfen 0850 911 0 911 numaralı çağrı merkezimiz ile iletişime geçebilirsiniz

Verdiğim kişisel veri ve iletişim bilgilerimin, Bayek Tedavi Sağlık Hizmetleri ve İşletmeciliği A.Ş., Penta Sağlık Hizmetleri A.Ş., Bayek Ağız ve Diş Sağlığı Hizmetleri ve İşletmeciliği A.Ş. (hepsi birlikte Bayındır Sağlık Grubu olarak anılacaktır) tarafından, 6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında Aydınlatma Metninde belirtilen amaç ve bağlı amaçlar dahilinde işlenmesine ve aktarılmasına muvafakatettiğimi beyan, kabul ve taahhüt ederim.

Bayek Tedavi Sağlık Hizmetleri ve İşletmeciliği A.Ş., Penta Sağlık Hizmetleri A.Ş., Bayek Ağız ve Diş Sağlığı Hizmetleri ve İşletmeciliği A.Ş. (hepsi birlikte Bayındır Sağlık Grubu olarak anılacaktır) tarafından her türlü bilgilendirme, etkinlik, duyuru, anket, tanıtım, açılış, davet vb. hatırlatmaları ile diğer sair iletişim çalışmaları kapsamında tarafıma ticari elektronik ileti (arama, SMS, e-posta vb.) gönderilmesini kabul ediyorum.

Lütfen Üstteki Kutucuğu işaretleyiniz!

Hastanemizde kaydınız var ise direkt randevu alabilmek için tıklayınız